
Monday, January 06, 2025 1:36:02 PM
Background of Bill Meury: https://www.hildred.com/team/bill-meury
Allergan's Chief Commercial Officer from 2015 to 2020. Bill was with Actavis in 2014 and was instrumental along with Brent Saunders in blocking Valeant's hostile takeover of Allergan. Actavis then took on the Allergan name and was eventually acquired by Abbvie in 2019.
https://www.reuters.com/article/business/allergan-agrees-to-66-billion-actavis-offer-valeant-walks-idUSKCN0J00W7/
There are indications that Allergan looked at potentially acquiring Revance some 8 to 10 years ago. If these rumors are true, then Bill Meury would have been actively involved in those discussions. If this is the case, then Bill has been patiently stalking Revance waiting for an opportunity like this for almost 10 years.
There is a reasonably strong possibility that Crown will increase their offer price.
Volume: | - |
Day Range: | |
Bid: | 3.84 |
Ask: | 3.10 |
Last Trade Time: | |
Total Trades: |
Recent RVNC News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/18/2025 11:07:05 AM
- Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC • PR Newswire (US) • 02/13/2025 10:45:00 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/12/2025 01:16:25 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 02/12/2025 12:50:10 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc.(RVNC) Shareholders • PR Newswire (US) • 02/10/2025 10:45:00 AM
- Crown Laboratories Completes Acquisition of Revance Therapeutics • Business Wire • 02/07/2025 08:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2025 01:06:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 08:59:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 08:59:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 08:58:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 08:58:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 08:57:14 PM
Wytec Prepares for 1st AI Gunshot Detection Pilot • WYTC • Apr 4, 2025 7:09 AM
ConnectM Receives $1.60 Per Share Buyout Offer from its Three Largest Institutional Investors • CNTM • Apr 2, 2025 9:00 AM
Nightfood Holdings Completes Acquisition of Carryout Supplies, Deepening Vertical Integration in AI-Powered Hospitality Automation • NGTF • Apr 2, 2025 8:30 AM
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City • AVAI • Apr 2, 2025 8:00 AM
Glidelogic Corp. Unveils ResearchMind - Pioneering AI-Driven Research Innovation for a Global Academic Community • GDLG • Apr 1, 2025 2:10 PM
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks • FITY • Apr 1, 2025 9:30 AM